Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.092036894086231e-53,341.3405275779377,41270.86190392123,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.0389243964129736e-50,0,0,74
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.1144152299744424e-40,131.2164705882353,11871.330009667166,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",8.592217586357064e-38,0,0,58
3,Oxidative phosphorylation WP623,9.015648172444681e-23,74.80778032036613,3797.279987748757,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.0097525953138042e-20,0,0,34
4,Nonalcoholic fatty liver disease WP4396,7.054446630497606e-22,12.577838577291383,612.5811626312524,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'BAX']",5.92573516961799e-20,0,0,48
5,Mitochondrial complex I assembly model OXPHOS system WP4324,3.3099734804052732e-18,113.40362811791383,4564.4497059668165,"['NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3']",2.2243021788323435e-16,0,0,26
6,Mitochondrial CIV Assembly WP4922,1.5453276879070717e-12,77.80449438202247,2115.9543115434662,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",8.653835052279602e-11,0,0,18
7,Mitochondrial complex III assembly WP4921,1.2881394703276135e-05,34.19555555555556,385.0326050795718,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0006183069457572545,0,0,8
8,mRNA Processing WP411,4.638761032907946e-05,7.852471200297288,78.355712320467,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'NCBP2', 'SRSF3', 'SNRPE', 'SNU13', 'HNRNPA1', 'SRSF9', 'LSM2']",0.0019482796338213372,0,0,11
9,Eukaryotic Transcription Initiation WP405,5.358112488277928e-05,17.093333333333334,168.101202172093,"['GTF2A2', 'TAF13', 'POLR2E', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.00200036199562376,0,0,8
10,Pyrimidine metabolism WP4022,0.00021275865754613146,5.140178571428572,43.46201966709756,"['POLE4', 'POLE3', 'NME2', 'POLR2E', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.007148690893550017,0,0,12
11,Cellular Proteostasis WP4918,0.0002513786126917625,inf,inf,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.007678473987675656,0,0,5
12,Ciliary landscape WP4352,0.00042565552350939105,3.433183856502242,26.6479616925641,"['NUDC', 'NDUFA5', 'SSNA1', 'H3F3A', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'PSMD7', 'EXOSC4', 'RAB14', 'NEFL', 'CALM2']",0.01191835465826295,0,0,16
13,7q11.23 copy number variation syndrome WP4932,0.0005295839553972545,3.750559284116331,28.292039599972036,"['ATP5PB', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'EIF4H', 'ATP5PO', 'GAPDH', 'VAMP2']",0.013687708385652116,0,0,14
14,Computational Model of Aerobic Glycolysis WP4629,0.0023607357199652806,8.52549889135255,51.5688839177076,"['LDHA', 'TPI1', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.05288048012722228,0,0,6
15,Cori Cycle WP1946,0.0023607357199652806,8.52549889135255,51.5688839177076,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.05288048012722228,0,0,6
16,Synaptic Vesicle Pathway WP2267,0.004741577373891313,3.842269187986652,20.561463309740134,"['RAB3A', 'SLC32A1', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'VAMP2', 'CPLX3']",0.09245246385932136,0,0,9
17,Proteasome Degradation WP183,0.004741577373891313,3.842269187986652,20.561463309740134,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMC3', 'H2AFZ', 'PSME1', 'PSMB10', 'PSMA7']",0.09245246385932136,0,0,9
18,Photodynamic therapy-induced unfolded protein response WP3613,0.004952810563892215,6.392461197339246,33.92990600891772,"['NARS', 'XBP1', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1']",0.09245246385932136,0,0,6
19,Cholesterol Biosynthesis Pathway WP197,0.005601621810008351,17.02212389380531,88.25459067468813,"['IDI1', 'HMGCS1', 'PMVK', 'MSMO1']",0.0990602593769898,0,0,4
20,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.006940083128622536,inf,inf,"['COX8A', 'GSTP1', 'COX5A']",0.11104133005796057,0,0,3
21,HIF1A and PPARG regulation of glycolysis WP2456,0.006940083128622536,inf,inf,"['LDHA', 'TPI1', 'GAPDH']",0.11104133005796057,0,0,3
22,Alzheimer's disease WP2059,0.008100667790918165,3.791604938271605,18.259644342081113,"['PSENEN', 'ATP5MD', 'CDK5', 'BAD', 'CYCS', 'CALM3', 'GAPDH', 'CALM2']",0.12371928989765925,0,0,8
23,Melanoma WP4685,0.013910087242505401,3.7291897891231964,15.942812168510947,"['BAD', 'GADD45A', 'KIT', 'BAX', 'CALM3', 'HRAS', 'CALM2']",0.19972555460067973,0,0,7
24,Fatty acid transporters WP5061,0.014266111042905694,8.508849557522124,36.16149095196699,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.19972555460067973,0,0,4
25,Non-small cell lung cancer WP4255,0.015386329703975276,4.259423503325943,17.78000864502907,"['BAD', 'GADD45A', 'CRABP1', 'CYCS', 'BAX', 'HRAS']",0.2067922712214277,0,0,6
26,VEGFA-VEGFR2 Signaling Pathway WP3888,0.020678192973856747,1.6034262477504087,6.219170285250201,"['SET', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'HRAS', 'SDF2L1', 'SSR4', 'RPL13A', 'CYCS', 'RPL27', 'RPL26', 'CALR', 'ALDOA', 'GAPDH', 'SLC25A11', 'PTMA', 'ARF6']",0.25765861742859075,0,0,31
27,Translation Factors WP107,0.020734783019220545,3.313972129732396,12.844765917905693,"['EEF1B2', 'EEF1G', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF1']",0.25765861742859075,0,0,7
28,Glycolysis and Gluconeogenesis WP534,0.022175696361890672,2.509498231363815,9.558072338658334,"['LDHA', 'TPI1', 'GOT1', 'MDH2', 'MPC2', 'PGAM1', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.25765861742859075,0,0,10
29,Methionine De Novo and Salvage Pathway WP3580,0.02379612914027811,12.752486187845303,47.67175644472497,"['AHCY', 'ODC1', 'TXN']",0.25765861742859075,0,0,3
30,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.02379612914027811,12.752486187845303,47.67175644472497,"['IDI1', 'HMGCS1', 'PMVK']",0.25765861742859075,0,0,3
31,Ferroptosis WP4313,0.024042130614277273,3.649984162179284,13.606949498001324,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.25765861742859075,0,0,6
32,Androgen receptor signaling pathway WP138,0.02453891594558007,2.8414814814814813,10.534778429716464,"['SUMO1', 'PRDX1', 'BAG1', 'DSTN', 'STUB1', 'PARK7', 'CALR', 'RAN']",0.25765861742859075,0,0,8
33,Parkinson's disease pathway WP2371,0.02702145117149536,4.255813953488372,15.368272930853406,"['PINK1', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.2751275028370437,0,0,5
34,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.02829714248455709,5.671091445427729,20.217409538079256,"['IDI1', 'HMGCS1', 'PMVK', 'MSMO1']",0.27964234925915243,0,0,4
35,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.03641652452152238,inf,inf,"['ELOB', 'ELOC']",0.33988756220087557,0,0,2
36,Mevalonate pathway WP3963,0.03641652452152238,inf,inf,"['HMGCS1', 'PMVK']",0.33988756220087557,0,0,2
37,NO/cGMP/PKG mediated Neuroprotection WP4008,0.04191293335515748,3.5455887781469175,11.24717783325061,"['BAD', 'NPPA', 'NEFL', 'CYCS', 'CALM2']",0.38061474614413277,0,0,5
38,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.051087943062801226,6.374585635359116,18.959335672966308,"['MAP1LC3A', 'ATG101', 'FTL']",0.44014227869490286,0,0,3
39,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.051087943062801226,6.374585635359116,18.959335672966308,"['EIF5', 'EIF3I', 'EIF1']",0.44014227869490286,0,0,3
40,EGF/EGFR signaling pathway WP437,0.056181908248583906,2.2714074074074073,6.539746466812727,"['NDUFA13', 'STMN1', 'AP2S1', 'NEDD8', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.47192802928810484,0,0,8
41,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.07392968527975126,3.4008849557522125,8.858083835737066,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.6058627866828395,0,0,4
42,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.09536948564714468,8.492273730684326,19.956814466761,"['MDH2', 'IDH3B']",0.7282760722145594,0,0,2
43,Hedgehog Signaling Pathway Netpath WP47,0.09536948564714468,8.492273730684326,19.956814466761,"['SMO', 'SAP18']",0.7282760722145594,0,0,2
44,Peroxiredoxin 2 induced ovarian failure WP4873,0.09536948564714468,8.492273730684326,19.956814466761,"['STAR', 'BAX']",0.7282760722145594,0,0,2
45,Amyotrophic lateral sclerosis (ALS) WP2447,0.10520186350320224,2.8333333333333335,6.3803104172921765,"['BAD', 'NEFL', 'BAX', 'SOD1']",0.7364130445224156,0,0,4
46,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.10520186350320224,2.8333333333333335,6.3803104172921765,"['ACLY', 'IDI1', 'HMGCS1', 'DBI']",0.7364130445224156,0,0,4
47,Base Excision Repair WP4752,0.10520186350320224,2.8333333333333335,6.3803104172921765,"['POLE4', 'NEIL2', 'APEX1', 'POLE3']",0.7364130445224156,0,0,4
48,GABA receptor Signaling WP4159,0.10520186350320224,2.8333333333333335,6.3803104172921765,"['SLC32A1', 'AP2S1', 'GAD2', 'AP2M1']",0.7364130445224156,0,0,4
49,Copper homeostasis WP3286,0.11078270716301736,2.361880152577827,5.19657231367717,"['SCO2', 'COX17', 'MT3', 'ATOX1', 'SOD1']",0.7477948576788646,0,0,5
50,Metabolic reprogramming in colon cancer WP4290,0.11127899667840246,2.1263858093126387,4.668936680589519,"['ACLY', 'LDHA', 'MDH2', 'PGAM1', 'PGK1', 'GAPDH']",0.7477948576788646,0,0,6
51,Selenium Micronutrient Network WP15,0.12555054330300405,1.6149233075769807,3.351041548225011,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'TXN', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.7728667430790457,0,0,11
52,Glycolysis in senescence WP5049,0.13261934855754953,3.1856353591160222,6.435850858477363,"['LDHA', 'PGK1', 'GAPDH']",0.7728667430790457,0,0,3
53,Glycosylation and related congenital defects WP4521,0.13261934855754953,3.1856353591160222,6.435850858477363,"['DPM2', 'DPM3', 'MPI']",0.7728667430790457,0,0,3
54,Kit receptor signaling pathway WP304,0.13261934855754953,3.1856353591160222,6.435850858477363,"['BAD', 'KIT', 'HRAS']",0.7728667430790457,0,0,3
55,Senescence and Autophagy in Cancer WP615,0.14102166138712544,1.664893359771727,3.2612626616174123,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'MAP1LC3A', 'HMGA1', 'ING1', 'HRAS', 'GABARAP', 'SLC39A3']",0.7728667430790457,0,0,9
56,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.14136698270365372,2.4279393173198485,4.750010903613281,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.7728667430790457,0,0,4
57,IL-18 signaling pathway WP4754,0.14301302704111243,1.394770173646578,2.7125763079948233,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'ARL4D', 'NACA', 'TMSB4X', 'STMN1', 'NPPA', 'CYCS', 'BAX', 'RPS11', 'ITM2C', 'ARF6']",0.7728667430790457,0,0,18
58,Cell cycle WP179,0.14935072095654925,1.7013333333333334,3.2350137191712536,"['CDKN2D', 'ANAPC13', 'PTTG1', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.7728667430790457,0,0,8
59,Ras signaling WP4223,0.16296060787314354,1.5951056729699666,2.893915325956114,"['GNG10', 'GNG3', 'BAD', 'KIT', 'RAC3', 'CALM3', 'CALM2', 'HRAS', 'ARF6']",0.7728667430790457,0,0,9
60,Serotonin and anxiety WP3947,0.1669428797810477,4.245033112582782,7.599048896969787,"['POMC', 'CRH']",0.7728667430790457,0,0,2
61,Alanine and aspartate metabolism WP106,0.1669428797810477,4.245033112582782,7.599048896969787,"['GOT1', 'GAD2']",0.7728667430790457,0,0,2
62,Autophagy WP4923,0.1669428797810477,4.245033112582782,7.599048896969787,"['MAP1LC3B', 'ATG101']",0.7728667430790457,0,0,2
63,Trans-sulfuration pathway WP2333,0.1669428797810477,4.245033112582782,7.599048896969787,"['AHCY', 'GOT1']",0.7728667430790457,0,0,2
64,Cysteine and methionine catabolism WP4504,0.1669428797810477,4.245033112582782,7.599048896969787,"['AHCY', 'GOT1']",0.7728667430790457,0,0,2
65,Dual hijack model of Vif in HIV infection WP3300,0.1669428797810477,4.245033112582782,7.599048896969787,"['ELOB', 'ELOC']",0.7728667430790457,0,0,2
66,Gastric acid production WP2596,0.1669428797810477,4.245033112582782,7.599048896969787,"['CCK', 'VIP']",0.7728667430790457,0,0,2
67,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.1669428797810477,4.245033112582782,7.599048896969787,"['BAD', 'HRAS']",0.7728667430790457,0,0,2
68,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.1669428797810477,4.245033112582782,7.599048896969787,"['PTTG1', 'ANAPC11']",0.7728667430790457,0,0,2
69,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.17495333952780653,1.931440652370885,3.3669568227657236,"['BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.7728667430790457,0,0,5
70,Cytosolic DNA-sensing pathway WP4655,0.17495333952780653,1.931440652370885,3.3669568227657236,"['POLR2E', 'POLR3H', 'POLR3K', 'POLR2K', 'POLR2L']",0.7728667430790457,0,0,5
71,Modulators of TCR signaling and T cell activation WP5072,0.17495333952780653,1.931440652370885,3.3669568227657236,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7', 'MEF2D']",0.7728667430790457,0,0,5
72,Endometrial cancer WP4155,0.1816202202416797,2.1238938053097347,3.6230176440428226,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.7728667430790457,0,0,4
73,TP53 network WP1742,0.1832845220922712,2.5478453038674034,4.3229687919422695,"['SUMO1', 'GADD45A', 'BAX']",0.7728667430790457,0,0,3
74,IL-6 signaling pathway WP364,0.1832845220922712,2.5478453038674034,4.3229687919422695,"['BAD', 'VIP', 'NR2F6']",0.7728667430790457,0,0,3
75,Nanomaterial induced apoptosis WP2507,0.1832845220922712,2.5478453038674034,4.3229687919422695,"['ENDOG', 'BAX', 'CYCS']",0.7728667430790457,0,0,3
76,The alternative pathway of fetal androgen synthesis WP4524,0.19091648712964523,inf,inf,['STAR'],0.7728667430790457,0,0,1
77,Cell Differentiation - Index WP2029,0.19091648712964523,inf,inf,['MEF2D'],0.7728667430790457,0,0,1
78,"Cerebral organic acidurias, including diseases WP4519",0.19091648712964523,inf,inf,['MDH2'],0.7728667430790457,0,0,1
79,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.19091648712964523,inf,inf,['MAP1LC3A'],0.7728667430790457,0,0,1
80,miRNA Biogenesis WP2338,0.19091648712964523,inf,inf,['RAN'],0.7728667430790457,0,0,1
81,Mitochondrial CII Assembly WP4920,0.19091648712964523,inf,inf,['SDHAF1'],0.7728667430790457,0,0,1
82,Nanoparticle triggered autophagic cell death WP2509,0.19091648712964523,inf,inf,['MAP1LC3A'],0.7728667430790457,0,0,1
83,Nanoparticle-mediated activation of receptor signaling WP2643,0.19091648712964523,inf,inf,['HRAS'],0.7728667430790457,0,0,1
84,DNA Repair Pathways Full Network WP4946,0.2112941933509256,1.7700258397932818,2.7515119565912456,"['POLE4', 'NEIL2', 'CENPX', 'APEX1', 'POLE3']",0.8352335172460119,0,0,5
85,G Protein Signaling Pathways WP35,0.2112941933509256,1.7700258397932818,2.7515119565912456,"['GNG10', 'GNG3', 'PRKAR1A', 'HRAS', 'CALM2']",0.8352335172460119,0,0,5
86,Pathways in clear cell renal cell carcinoma WP4018,0.21470797181254225,1.565687248086921,2.408772951073397,"['ACLY', 'LDHA', 'TPI1', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.8388590526629558,0,0,7
87,Genotoxicity pathway WP4286,0.22506385811066304,1.8874139626352016,2.8148346436882297,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.8593347309679862,0,0,4
88,PPAR signaling pathway WP3942,0.22506385811066304,1.8874139626352016,2.8148346436882297,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.8593347309679862,0,0,4
89,MET in type 1 papillary renal cell carcinoma WP4205,0.23796194543828317,2.1226519337016576,3.047373597831021,"['BAD', 'RPL11', 'HRAS']",0.8636243836846683,0,0,3
90,p38 MAPK Signaling Pathway WP400,0.23796194543828317,2.1226519337016576,3.047373597831021,"['DDIT3', 'HRAS', 'MEF2D']",0.8636243836846683,0,0,3
91,Tumor suppressor activity of SMARCB1 WP4204,0.24417951324417705,2.8292862398822662,3.988873772257635,"['SMO', 'H3F3A']",0.8636243836846683,0,0,2
92,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.24417951324417705,2.8292862398822662,3.988873772257635,"['BAD', 'BAX']",0.8636243836846683,0,0,2
93,Lipid Metabolism Pathway WP3965,0.24417951324417705,2.8292862398822662,3.988873772257635,"['ACLY', 'PRKAR1A']",0.8636243836846683,0,0,2
94,Nucleotide metabolism WP404,0.24417951324417705,2.8292862398822662,3.988873772257635,"['NME2', 'OAZ1']",0.8636243836846683,0,0,2
95,RalA downstream regulated genes WP2290,0.24417951324417705,2.8292862398822662,3.988873772257635,"['RAC3', 'HRAS']",0.8636243836846683,0,0,2
96,Small cell lung cancer WP4658,0.24976157706273247,1.6334440753045405,2.265992856240713,"['GADD45A', 'CYCS', 'BAX', 'CKS1B', 'SKP1']",0.8651535040523517,0,0,5
97,Amino Acid metabolism WP3925,0.24976157706273247,1.6334440753045405,2.265992856240713,"['ACLY', 'LDHA', 'GOT1', 'MDH2', 'ODC1']",0.8651535040523517,0,0,5
98,Pancreatic adenocarcinoma pathway WP4263,0.27077631714642875,1.6982300884955752,2.2186734122823517,"['BAD', 'GADD45A', 'RAC3', 'BAX']",0.9189984097090915,0,0,4
99,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.27077631714642875,1.6982300884955752,2.2186734122823517,"['BAD', 'STMN1', 'BAX', 'HRAS']",0.9189984097090915,0,0,4
100,Aryl Hydrocarbon Receptor Netpath WP2586,0.2948591191886387,1.8189423835832677,2.2213972077010067,"['CDC37', 'AIP', 'HRAS']",0.9359669235415535,0,0,3
101,IL-3 signaling pathway WP286,0.2948591191886387,1.8189423835832677,2.2213972077010067,"['YWHAB', 'BAD', 'HRAS']",0.9359669235415535,0,0,3
102,Imatinib and Chronic Myeloid Leukemia WP3640,0.2948591191886387,1.8189423835832677,2.2213972077010067,"['GADD45A', 'KIT', 'PIM2']",0.9359669235415535,0,0,3
103,Notch Signaling Pathway Netpath WP61,0.2948591191886387,1.8189423835832677,2.2213972077010067,"['PSENEN', 'SKP1', 'DLL3']",0.9359669235415535,0,0,3
104,One-carbon metabolism and related pathways WP3940,0.2948591191886387,1.8189423835832677,2.2213972077010067,"['GPX4', 'GAD2', 'SOD1']",0.9359669235415535,0,0,3
105,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.2948591191886387,1.8189423835832677,2.2213972077010067,"['STAR', 'CALM3', 'CALM2']",0.9359669235415535,0,0,3
106,Myometrial relaxation and contraction pathways WP289,0.30121210832723655,1.2630992196209587,1.5156440147048205,"['RGS4', 'GNG3', 'PRKAR1A', 'YWHAB', 'GSTO1', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.9359669235415535,0,0,11
107,Type 2 papillary renal cell carcinoma WP4241,0.3223143516034784,2.121412803532009,2.4019228960400536,"['ELOB', 'ELOC']",0.9359669235415535,0,0,2
108,DNA Mismatch Repair WP531,0.3223143516034784,2.121412803532009,2.4019228960400536,"['POLE4', 'POLE3']",0.9359669235415535,0,0,2
109,Histone Modifications WP2369,0.3223143516034784,2.121412803532009,2.4019228960400536,"['SET', 'H3F3A']",0.9359669235415535,0,0,2
110,Integrated breast cancer pathway WP1984,0.33893259122872055,1.3405298167814215,1.4503916473972571,"['GADD45A', 'BAD', 'ODC1', 'BAX', 'PHB', 'FAU']",0.9359669235415535,0,0,6
111,Serotonin and anxiety-related events WP3944,0.34541636464033526,4.241455347298787,4.508687119945623,['CRH'],0.9359669235415535,0,0,1
112,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.34541636464033526,4.241455347298787,4.508687119945623,['CDC37'],0.9359669235415535,0,0,1
113,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.34541636464033526,4.241455347298787,4.508687119945623,['DLL3'],0.9359669235415535,0,0,1
114,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.34541636464033526,4.241455347298787,4.508687119945623,['HMGCS1'],0.9359669235415535,0,0,1
115,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.34541636464033526,4.241455347298787,4.508687119945623,['ACLY'],0.9359669235415535,0,0,1
116,TCA cycle in senescence WP5050,0.34541636464033526,4.241455347298787,4.508687119945623,['GOT1'],0.9359669235415535,0,0,1
117,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.34541636464033526,4.241455347298787,4.508687119945623,['CCK'],0.9359669235415535,0,0,1
118,Energy Metabolism WP1541,0.34541636464033526,4.241455347298787,4.508687119945623,['MEF2D'],0.9359669235415535,0,0,1
119,Glycerolipids and Glycerophospholipids WP4722,0.34541636464033526,4.241455347298787,4.508687119945623,['CDIPT'],0.9359669235415535,0,0,1
120,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.34541636464033526,4.241455347298787,4.508687119945623,['HRAS'],0.9359669235415535,0,0,1
121,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.34541636464033526,4.241455347298787,4.508687119945623,['AHCY'],0.9359669235415535,0,0,1
122,MTHFR deficiency WP4288,0.34541636464033526,4.241455347298787,4.508687119945623,['CYCS'],0.9359669235415535,0,0,1
123,NOTCH1 regulation of endothelial cell calcification WP3413,0.34541636464033526,4.241455347298787,4.508687119945623,['DLL3'],0.9359669235415535,0,0,1
124,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.34541636464033526,4.241455347298787,4.508687119945623,['MAS1'],0.9359669235415535,0,0,1
125,Aryl Hydrocarbon Receptor Pathway WP2873,0.3524186584391131,1.591160220994475,1.6594773844920185,"['CDC37', 'AIP', 'BAX']",0.9397830891709682,0,0,3
126,CAMKK2  Pathway WP4874,0.3524186584391131,1.591160220994475,1.6594773844920185,"['FIS1', 'MAP1LC3A', 'CALM2']",0.9397830891709682,0,0,3
127,Sleep regulation WP3591,0.3655017538470529,1.4144542772861357,1.4236258835732807,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9669967660835417,0,0,4
128,Vitamin D-sensitive calcium signaling in depression WP4698,0.39819232930976434,1.6966887417218544,1.5623451832649748,"['GPX4', 'PVALB']",0.9799915802061652,0,0,2
129,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.39819232930976434,1.6966887417218544,1.5623451832649748,"['CD63', 'SOD1']",0.9799915802061652,0,0,2
130,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.39819232930976434,1.6966887417218544,1.5623451832649748,"['STAR', 'HRAS']",0.9799915802061652,0,0,2
131,Nucleotide Excision Repair WP4753,0.39819232930976434,1.6966887417218544,1.5623451832649748,"['POLE4', 'POLE3']",0.9799915802061652,0,0,2
132,PDGF Pathway WP2526,0.39819232930976434,1.6966887417218544,1.5623451832649748,"['ARFIP2', 'HRAS']",0.9799915802061652,0,0,2
133,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4093514528576889,1.4139963167587477,1.262954918491397,"['BAD', 'BAX', 'HRAS']",0.9799915802061652,0,0,3
134,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.41295021881536315,1.3053097345132743,1.1544527765859527,"['POMC', 'BAD', 'NPPA', 'HRAS']",0.9799915802061652,0,0,4
135,TNF-alpha signaling pathway WP231,0.41354163254890597,1.2122267975926513,1.0703927301800957,"['BAD', 'CDC37', 'BAX', 'TXN', 'HRAS', 'SKP1']",0.9799915802061652,0,0,6
136,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.41354163254890597,1.2122267975926513,1.0703927301800957,"['PSMD8', 'PSMC5', 'PSMD7', 'PSMC3', 'UBE2L6', 'STUB1']",0.9799915802061652,0,0,6
137,DNA damage response WP707,0.4595755262140429,1.2117572692793932,0.9420830938697713,"['CDK5', 'GADD45A', 'CYCS', 'BAX']",0.9799915802061652,0,0,4
138,miRNA regulation of DNA damage response WP1530,0.4595755262140429,1.2117572692793932,0.9420830938697713,"['CDK5', 'GADD45A', 'CYCS', 'BAX']",0.9799915802061652,0,0,4
139,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4646377076951102,1.2722651933701656,0.9751878359907022,"['APEX1', 'HRAS', 'MYL12B']",0.9799915802061652,0,0,3
140,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.4646377076951102,1.2722651933701656,0.9751878359907022,"['LDHA', 'PGK1', 'BAX']",0.9799915802061652,0,0,3
141,Endothelin Pathways WP2197,0.46982823242488064,1.4135393671817513,1.0677708366425358,"['RIIAD1', 'CALM2']",0.9799915802061652,0,0,2
142,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.46982823242488064,1.4135393671817513,1.0677708366425358,"['BANF1', 'HRAS']",0.9799915802061652,0,0,2
143,G13 Signaling Pathway WP524,0.46982823242488064,1.4135393671817513,1.0677708366425358,"['ARHGDIG', 'CALM2']",0.9799915802061652,0,0,2
144,Galanin receptor pathway WP4970,0.46982823242488064,1.4135393671817513,1.0677708366425358,"['POMC', 'VAMP2']",0.9799915802061652,0,0,2
145,ACE Inhibitor Pathway WP554,0.4704397280534104,2.1201764057331864,1.5987983770902812,['MAS1'],0.9799915802061652,0,0,1
146,Airway smooth muscle cell contraction WP4962,0.4704397280534104,2.1201764057331864,1.5987983770902812,['CALM2'],0.9799915802061652,0,0,1
147,Splicing factor NOVA regulated synaptic proteins WP4148,0.4704397280534104,2.1201764057331864,1.5987983770902812,['APLP2'],0.9799915802061652,0,0,1
148,Trans-sulfuration and one-carbon metabolism WP2525,0.4704397280534104,2.1201764057331864,1.5987983770902812,['AHCY'],0.9799915802061652,0,0,1
149,Dopamine metabolism WP2436,0.4704397280534104,2.1201764057331864,1.5987983770902812,['SOD1'],0.9799915802061652,0,0,1
150,Fatty acid beta-oxidation WP143,0.4704397280534104,2.1201764057331864,1.5987983770902812,['TPI1'],0.9799915802061652,0,0,1
151,Fatty Acid Biosynthesis WP357,0.4704397280534104,2.1201764057331864,1.5987983770902812,['ACLY'],0.9799915802061652,0,0,1
152,Gastric Cancer Network 1 WP2361,0.4704397280534104,2.1201764057331864,1.5987983770902812,['H3F3A'],0.9799915802061652,0,0,1
153,Glycerophospholipid Biosynthetic Pathway WP2533,0.4704397280534104,2.1201764057331864,1.5987983770902812,['CDIPT'],0.9799915802061652,0,0,1
154,Iron metabolism in placenta WP2007,0.4704397280534104,2.1201764057331864,1.5987983770902812,['FTH1'],0.9799915802061652,0,0,1
155,Overview of nanoparticle effects WP3287,0.4704397280534104,2.1201764057331864,1.5987983770902812,['BAX'],0.9799915802061652,0,0,1
156,Purine metabolism and related disorders WP4224,0.4704397280534104,2.1201764057331864,1.5987983770902812,['APRT'],0.9799915802061652,0,0,1
157,Purine metabolism WP4792,0.4704397280534104,2.1201764057331864,1.5987983770902812,['APRT'],0.9799915802061652,0,0,1
158,Rett syndrome causing genes WP4312,0.4704397280534104,2.1201764057331864,1.5987983770902812,['IMPDH2'],0.9799915802061652,0,0,1
159,16p11.2 proximal deletion syndrome WP4949,0.5048506860167377,1.1306784660766962,0.772810324607351,"['ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9799915802061652,0,0,4
160,Exercise-induced Circadian Regulation WP410,0.5048506860167377,1.1306784660766962,0.772810324607351,"['IDI1', 'SUMO1', 'GSTP1', 'STBD1']",0.9799915802061652,0,0,4
161,Calcium Regulation in the Cardiac Cell WP536,0.5053616010536883,1.06,0.7234299281069578,"['RGS4', 'GNG3', 'PRKAR1A', 'YWHAB', 'CALM3', 'CALR', 'CALM2', 'YWHAH']",0.9799915802061652,0,0,8
162,TGF-beta Signaling Pathway WP366,0.5341840282336436,1.0598006644518272,0.6645107835096813,"['PARD6A', 'CITED1', 'SUMO1', 'STRAP', 'SKP1']",0.9799915802061652,0,0,5
163,Insulin Signaling WP481,0.5341840282336436,1.0598006644518272,0.6645107835096813,"['XBP1', 'HRAS', 'PFKM', 'VAMP2', 'ARF6']",0.9799915802061652,0,0,5
164,Urea cycle and associated pathways WP4595,0.5360757038720241,1.2112898139388206,0.7552148391258133,"['GOT1', 'MDH2']",0.9799915802061652,0,0,2
165,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5360757038720241,1.2112898139388206,0.7552148391258133,"['CDK5', 'BAX']",0.9799915802061652,0,0,2
166,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5360757038720241,1.2112898139388206,0.7552148391258133,"['RAB3A', 'NEFL']",0.9799915802061652,0,0,2
167,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5360757038720241,1.2112898139388206,0.7552148391258133,"['TKFC', 'PIN1']",0.9799915802061652,0,0,2
168,Oxidative Stress WP408,0.5360757038720241,1.2112898139388206,0.7552148391258133,"['TXN2', 'SOD1']",0.9799915802061652,0,0,2
169,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5551852759964261,1.0037468532287337,0.5906582388060382,"['PRKAR1A', 'YWHAB', 'TAC1', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9799915802061652,0,0,9
170,Leptin signaling pathway WP2034,0.5674200139180242,1.0596685082872928,0.6004669716529623,"['BAD', 'BAX', 'HRAS']",0.9799915802061652,0,0,3
171,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5716052686651635,1.4130834252113194,0.7903469080731309,['HRAS'],0.9799915802061652,0,0,1
172,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5716052686651635,1.4130834252113194,0.7903469080731309,['MEF2D'],0.9799915802061652,0,0,1
173,Sulfation Biotransformation Reaction WP692,0.5716052686651635,1.4130834252113194,0.7903469080731309,['SULT4A1'],0.9799915802061652,0,0,1
174,Biomarkers for urea cycle disorders WP4583,0.5716052686651635,1.4130834252113194,0.7903469080731309,['GOT1'],0.9799915802061652,0,0,1
175,Cell Differentiation - Index expanded WP2023,0.5716052686651635,1.4130834252113194,0.7903469080731309,['MEF2D'],0.9799915802061652,0,0,1
176,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.5716052686651635,1.4130834252113194,0.7903469080731309,['VIP'],0.9799915802061652,0,0,1
177,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5716052686651635,1.4130834252113194,0.7903469080731309,['H3F3A'],0.9799915802061652,0,0,1
178,Gastric Cancer Network 2 WP2363,0.5716052686651635,1.4130834252113194,0.7903469080731309,['S100A6'],0.9799915802061652,0,0,1
179,Hedgehog Signaling Pathway WP4249,0.5716052686651635,1.4130834252113194,0.7903469080731309,['SMO'],0.9799915802061652,0,0,1
180,Intraflagellar transport proteins binding to dynein WP4532,0.5716052686651635,1.4130834252113194,0.7903469080731309,['DYNLL1'],0.9799915802061652,0,0,1
181,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5716052686651635,1.4130834252113194,0.7903469080731309,['BAX'],0.9799915802061652,0,0,1
182,Nanoparticle triggered regulated necrosis WP2513,0.5716052686651635,1.4130834252113194,0.7903469080731309,['FTL'],0.9799915802061652,0,0,1
183,One-carbon metabolism WP241,0.5716052686651635,1.4130834252113194,0.7903469080731309,['AHCY'],0.9799915802061652,0,0,1
184,PDGFR-beta pathway WP3972,0.5716052686651635,1.4130834252113194,0.7903469080731309,['HRAS'],0.9799915802061652,0,0,1
185,Phosphoinositides metabolism WP4971,0.5716052686651635,1.4130834252113194,0.7903469080731309,['PIP4P1'],0.9799915802061652,0,0,1
186,PPAR-alpha pathway WP2878,0.5716052686651635,1.4130834252113194,0.7903469080731309,['DBI'],0.9799915802061652,0,0,1
187,Hepatitis B infection WP4666,0.5717992581278404,1.0090702947845804,0.5640372946821615,"['YWHAB', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9799915802061652,0,0,5
188,Acute viral myocarditis WP4298,0.5897664460745206,0.9971369078604894,0.5265168798166944,"['ENDOG', 'RAC3', 'CYCS', 'BAX']",0.9799915802061652,0,0,4
189,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5897664460745206,0.9971369078604894,0.5265168798166944,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9799915802061652,0,0,4
190,Regulation of Actin Cytoskeleton WP51,0.5897664460745206,0.9971369078604894,0.5265168798166944,"['TMSB4X', 'BRK1', 'RAC3', 'ACTG1']",0.9799915802061652,0,0,4
191,Cardiac Hypertrophic Response WP2795,0.5963798062458251,1.0596026490066226,0.5476848276325673,"['NPPA', 'CALM2']",0.9799915802061652,0,0,2
192,Cardiac Progenitor Differentiation WP2406,0.5963798062458251,1.0596026490066226,0.5476848276325673,"['MESP1', 'KIT']",0.9799915802061652,0,0,2
193,Unfolded protein response WP4925,0.5963798062458251,1.0596026490066226,0.5476848276325673,"['XBP1', 'DDIT3']",0.9799915802061652,0,0,2
194,Common Pathways Underlying Drug Addiction WP2636,0.5963798062458251,1.0596026490066226,0.5476848276325673,"['CALM2', 'ACTG1']",0.9799915802061652,0,0,2
195,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5963798062458251,1.0596026490066226,0.5476848276325673,"['H2AFZ', 'H3F3A']",0.9799915802061652,0,0,2
196,p53 transcriptional gene network WP4963,0.5963798062458251,1.0596026490066226,0.5476848276325673,"['GADD45A', 'BAX']",0.9799915802061652,0,0,2
197,Adipogenesis WP236,0.623122822265984,0.9413648681941365,0.4452765336767925,"['GADD45A', 'DDIT3', 'HMGA1', 'NDN', 'MIF', 'MEF2D']",0.9799915802061652,0,0,6
198,AGE/RAGE pathway WP2324,0.6505933472645344,0.9416237429482462,0.4047762602794803,"['CYCS', 'SOD1']",0.9799915802061652,0,0,2
199,ErbB signaling pathway WP673,0.6505933472645344,0.9416237429482462,0.4047762602794803,"['BAD', 'HRAS']",0.9799915802061652,0,0,2
200,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6505933472645344,0.9416237429482462,0.4047762602794803,"['CYCS', 'ACTG1']",0.9799915802061652,0,0,2
201,Glycogen Synthesis and Degradation WP500,0.6505933472645344,0.9416237429482462,0.4047762602794803,"['CALM3', 'CALM2']",0.9799915802061652,0,0,2
202,Integrated Cancer Pathway WP1971,0.6505933472645344,0.9416237429482462,0.4047762602794803,"['BAD', 'BAX']",0.9799915802061652,0,0,2
203,Integrin-mediated Cell Adhesion WP185,0.6505933472645344,0.9416237429482462,0.4047762602794803,"['RAC3', 'HRAS']",0.9799915802061652,0,0,2
204,Regulation of Microtubule Cytoskeleton WP2038,0.6505933472645344,0.9416237429482462,0.4047762602794803,"['PARD6A', 'STMN1']",0.9799915802061652,0,0,2
205,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6534616314176737,1.0595369349503858,0.45080272672813915,['HRAS'],0.9799915802061652,0,0,1
206,BDNF-TrkB Signaling WP3676,0.6534616314176737,1.0595369349503858,0.45080272672813915,['HRAS'],0.9799915802061652,0,0,1
207,Cannabinoid receptor signaling WP3869,0.6534616314176737,1.0595369349503858,0.45080272672813915,['PRKAR1A'],0.9799915802061652,0,0,1
208,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6534616314176737,1.0595369349503858,0.45080272672813915,['STAR'],0.9799915802061652,0,0,1
209,ERK Pathway in Huntington's Disease WP3853,0.6534616314176737,1.0595369349503858,0.45080272672813915,['HRAS'],0.9799915802061652,0,0,1
210,Ethanol effects on histone modifications WP3996,0.6534616314176737,1.0595369349503858,0.45080272672813915,['AHCY'],0.9799915802061652,0,0,1
211,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6534616314176737,1.0595369349503858,0.45080272672813915,['HRAS'],0.9799915802061652,0,0,1
212,Genes targeted by miRNAs in adipocytes WP1992,0.6534616314176737,1.0595369349503858,0.45080272672813915,['TMSB4X'],0.9799915802061652,0,0,1
213,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6534616314176737,1.0595369349503858,0.45080272672813915,['LDHA'],0.9799915802061652,0,0,1
214,IL-7 signaling pathway WP205,0.6534616314176737,1.0595369349503858,0.45080272672813915,['BAD'],0.9799915802061652,0,0,1
215,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6534616314176737,1.0595369349503858,0.45080272672813915,['SUPT4H1'],0.9799915802061652,0,0,1
216,Nicotine Activity on Dopaminergic Neurons WP1602,0.6534616314176737,1.0595369349503858,0.45080272672813915,['CDK5'],0.9799915802061652,0,0,1
217,Osteoclast Signaling WP12,0.6534616314176737,1.0595369349503858,0.45080272672813915,['ATP6V1G1'],0.9799915802061652,0,0,1
218,Physiological and pathological hypertrophy of the heart WP1528,0.6534616314176737,1.0595369349503858,0.45080272672813915,['CALM2'],0.9799915802061652,0,0,1
219,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6534616314176737,1.0595369349503858,0.45080272672813915,['BAX'],0.9799915802061652,0,0,1
220,Oxidative Damage WP3941,0.6571020956923632,0.9078137332280979,0.3812053988320702,"['BAD', 'GADD45A', 'CYCS']",0.9799915802061652,0,0,3
221,Fragile X Syndrome  WP4549,0.696607370484633,0.8470718232044199,0.30624470584475383,"['PRKAR1A', 'AP2S1', 'AP2M1']",0.9799915802061652,0,0,3
222,DNA damage response (only ATM dependent) WP710,0.6995430193797879,0.8469026548672567,0.3026220204947657,"['BAD', 'RAC3', 'BAX', 'HRAS']",0.9799915802061652,0,0,4
223,Gastrin signaling pathway WP4659,0.6995430193797879,0.8469026548672567,0.3026220204947657,"['BAD', 'KIT', 'HRAS', 'MEF2D']",0.9799915802061652,0,0,4
224,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7196910104755614,0.8474090407938258,0.278741061730346,['HRAS'],0.9799915802061652,0,0,1
225,Biogenic Amine Synthesis WP550,0.7196910104755614,0.8474090407938258,0.278741061730346,['GAD2'],0.9799915802061652,0,0,1
226,Bladder cancer WP2828,0.7196910104755614,0.8474090407938258,0.278741061730346,['HRAS'],0.9799915802061652,0,0,1
227,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7196910104755614,0.8474090407938258,0.278741061730346,['PIM2'],0.9799915802061652,0,0,1
228,Genes related to primary cilium development (based on CRISPR) WP4536,0.7196910104755614,0.8474090407938258,0.278741061730346,['DYNLL1'],0.9799915802061652,0,0,1
229,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7196910104755614,0.8474090407938258,0.278741061730346,['SMO'],0.9799915802061652,0,0,1
230,Interleukin-11 Signaling Pathway WP2332,0.7196910104755614,0.8474090407938258,0.278741061730346,['HRAS'],0.9799915802061652,0,0,1
231,MAPK Cascade WP422,0.7196910104755614,0.8474090407938258,0.278741061730346,['HRAS'],0.9799915802061652,0,0,1
232,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7196910104755614,0.8474090407938258,0.278741061730346,['BAX'],0.9799915802061652,0,0,1
233,miRNA regulation of prostate cancer signaling pathways WP3981,0.7196910104755614,0.8474090407938258,0.278741061730346,['BAD'],0.9799915802061652,0,0,1
234,Notch Signaling WP268,0.7196910104755614,0.8474090407938258,0.278741061730346,['DLL3'],0.9799915802061652,0,0,1
235,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7196910104755614,0.8474090407938258,0.278741061730346,['HRAS'],0.9799915802061652,0,0,1
236,Ectoderm Differentiation WP2858,0.732561708057695,0.7939226519337017,0.2470748413405466,"['MAFB', 'ARHGDIG', 'LY6E']",0.9799915802061652,0,0,3
237,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7414241636100188,0.7700180614087899,0.23037584929155397,"['BEX3', 'RNF7']",0.9799915802061652,0,0,2
238,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7414241636100188,0.7700180614087899,0.23037584929155397,"['NPPA', 'CALM2']",0.9799915802061652,0,0,2
239,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7414241636100188,0.7700180614087899,0.23037584929155397,"['IFI27L2', 'HRAS']",0.9799915802061652,0,0,2
240,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7599927511640764,0.7695092518101367,0.21118903137471365,"['RAB3A', 'CDK5', 'BAD', 'HRAS']",0.9799915802061652,0,0,4
241,Proximal tubule transport WP4917,0.7599927511640764,0.7695092518101367,0.21118903137471365,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9799915802061652,0,0,4
242,Corticotropin-releasing hormone signaling pathway WP2355,0.7650687904573502,0.7470263243418914,0.2000458260758834,"['POMC', 'STAR', 'CRH']",0.9799915802061652,0,0,3
243,Folate Metabolism WP176,0.7650687904573502,0.7470263243418914,0.2000458260758834,"['AHCY', 'GPX4', 'SOD1']",0.9799915802061652,0,0,3
244,Circadian rhythm related genes WP3594,0.7684380451838255,0.8096229853501526,0.2132509191512338,"['AHCY', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1', 'NR2F6', 'HCRTR1']",0.9799915802061652,0,0,9
245,Alpha 6 Beta 4 signaling pathway WP244,0.7732740465082286,0.7059904446894524,0.18152551268989411,['HRAS'],0.9799915802061652,0,0,1
246,Apoptosis Modulation by HSP70 WP384,0.7732740465082286,0.7059904446894524,0.18152551268989411,['CYCS'],0.9799915802061652,0,0,1
247,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7732740465082286,0.7059904446894524,0.18152551268989411,['CALM2'],0.9799915802061652,0,0,1
248,Target Of Rapamycin (TOR) Signaling WP1471,0.7732740465082286,0.7059904446894524,0.18152551268989411,['IDI1'],0.9799915802061652,0,0,1
249,Canonical and non-canonical Notch signaling WP3845,0.7732740465082286,0.7059904446894524,0.18152551268989411,['DLL3'],0.9799915802061652,0,0,1
250,Transcriptional cascade regulating adipogenesis WP4211,0.7732740465082286,0.7059904446894524,0.18152551268989411,['DDIT3'],0.9799915802061652,0,0,1
251,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7732740465082286,0.7059904446894524,0.18152551268989411,['PPIB'],0.9799915802061652,0,0,1
252,Urea cycle and metabolism of amino groups WP497,0.7732740465082286,0.7059904446894524,0.18152551268989411,['ODC1'],0.9799915802061652,0,0,1
253,Development of ureteric collection system WP5053,0.7732740465082286,0.7059904446894524,0.18152551268989411,['SMO'],0.9799915802061652,0,0,1
254,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7732740465082286,0.7059904446894524,0.18152551268989411,['MAP1LC3A'],0.9799915802061652,0,0,1
255,Glutathione metabolism WP100,0.7732740465082286,0.7059904446894524,0.18152551268989411,['GPX4'],0.9799915802061652,0,0,1
256,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7732740465082286,0.7059904446894524,0.18152551268989411,['DDIT3'],0.9799915802061652,0,0,1
257,IL-2 signaling pathway WP49,0.7732740465082286,0.7059904446894524,0.18152551268989411,['HRAS'],0.9799915802061652,0,0,1
258,Neovascularisation processes WP4331,0.7732740465082286,0.7059904446894524,0.18152551268989411,['KIT'],0.9799915802061652,0,0,1
259,Nuclear receptors WP170,0.7732740465082286,0.7059904446894524,0.18152551268989411,['NR2F6'],0.9799915802061652,0,0,1
260,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7732740465082286,0.7059904446894524,0.18152551268989411,['LDHA'],0.9799915802061652,0,0,1
261,Prion disease pathway WP3995,0.7732740465082286,0.7059904446894524,0.18152551268989411,['HSP90B1'],0.9799915802061652,0,0,1
262,SARS-CoV-2 mitochondrial interactions WP5038,0.7732740465082286,0.7059904446894524,0.18152551268989411,['PHB'],0.9799915802061652,0,0,1
263,3q29 copy number variation syndrome WP4906,0.7787433092709706,0.7056659308314938,0.1764685612372707,"['NCBP2', 'DYNLL1']",0.9799915802061652,0,0,2
264,Thermogenesis WP4321,0.7787433092709706,0.7056659308314938,0.1764685612372707,"['HRAS', 'ACTG1']",0.9799915802061652,0,0,2
265,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7787433092709706,0.7056659308314938,0.1764685612372707,"['HMGCS1', 'CALM2']",0.9799915802061652,0,0,2
266,Endochondral Ossification WP474,0.7787433092709706,0.7056659308314938,0.1764685612372707,"['HMGCS1', 'CALM2']",0.9799915802061652,0,0,2
267,Pre-implantation embryo WP3527,0.7787433092709706,0.7056659308314938,0.1764685612372707,"['DDIT3', 'HMGA1']",0.9799915802061652,0,0,2
268,22q11.2 copy number variation syndrome WP4657,0.78646678025207,0.7358599461331281,0.17675708737537787,"['RANBP1', 'MRPL40', 'DGCR6L', 'RAN']",0.9860180528533414,0,0,4
269,Hippo-Merlin Signaling Dysregulation WP4541,0.7942858047370787,0.7053406998158379,0.16244837570630957,"['PRKAR1A', 'KIT', 'HRAS']",0.9921190720879496,0,0,3
270,Focal Adhesion WP306,0.8054526719082101,0.7291786000687364,0.15775839844752476,"['BAD', 'RAC3', 'HRAS', 'MYL12B', 'ACTG1']",0.9940742069707549,0,0,5
271,Zinc homeostasis WP3529,0.8112545308430773,0.6512141280353201,0.1362166901978632,"['MT3', 'SLC39A3']",0.9940742069707549,0,0,2
272,G1 to S cell cycle control WP45,0.8112545308430773,0.6512141280353201,0.1362166901978632,"['CDKN2D', 'GADD45A']",0.9940742069707549,0,0,2
273,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8166233707080138,0.6049771617577572,0.12255462848171714,['ACTG1'],0.9940742069707549,0,0,1
274,Melatonin metabolism and effects WP3298,0.8166233707080138,0.6049771617577572,0.12255462848171714,['CALM2'],0.9940742069707549,0,0,1
275,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8166233707080138,0.6049771617577572,0.12255462848171714,['BAX'],0.9940742069707549,0,0,1
276,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8166233707080138,0.6049771617577572,0.12255462848171714,['GSTP1'],0.9940742069707549,0,0,1
277,Breast cancer pathway WP4262,0.8223101030113044,0.7246753246753247,0.1417738143436537,"['GADD45A', 'KIT', 'BAX', 'HRAS', 'SKP1', 'DLL3']",0.9940742069707549,0,0,6
278,Prader-Willi and Angelman Syndrome WP3998,0.8394313369699977,0.6045411542100284,0.10581319864681975,"['POMC', 'NDN']",0.9940742069707549,0,0,2
279,Prolactin Signaling Pathway WP2037,0.8394313369699977,0.6045411542100284,0.10581319864681975,"['PPIB', 'HRAS']",0.9940742069707549,0,0,2
280,Retinoblastoma gene in cancer WP2446,0.8394313369699977,0.6045411542100284,0.10581319864681975,"['H2AFZ', 'STMN1']",0.9940742069707549,0,0,2
281,Apoptosis WP254,0.8436458911920532,0.634475138121547,0.10787500642361966,"['BAD', 'CYCS', 'BAX']",0.9940742069707549,0,0,3
282,Striated Muscle Contraction Pathway WP383,0.8516917512519132,0.5292171995589857,0.0849555608845533,['ACTG1'],0.9940742069707549,0,0,1
283,ATM Signaling Pathway WP2516,0.8516917512519132,0.5292171995589857,0.0849555608845533,['GADD45A'],0.9940742069707549,0,0,1
284,DNA Replication WP466,0.8516917512519132,0.5292171995589857,0.0849555608845533,['UBA52'],0.9940742069707549,0,0,1
285,Joubert Syndrome WP4656,0.8516917512519132,0.5292171995589857,0.0849555608845533,['ARL2'],0.9940742069707549,0,0,1
286,Pathways affected in adenoid cystic carcinoma WP3651,0.8516917512519132,0.5292171995589857,0.0849555608845533,['HRAS'],0.9940742069707549,0,0,1
287,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8516917512519132,0.5292171995589857,0.0849555608845533,['BAX'],0.9940742069707549,0,0,1
288,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8520636059749327,0.6504424778761062,0.10413200312284505,"['STRAP', 'HRAS', 'MEF2D', 'DLL3']",0.9940742069707549,0,0,4
289,ATM Signaling Network in Development and Disease  WP3878,0.8800596679417653,0.4702927845154968,0.060087225365049436,['CDK5'],0.9988592418816441,0,0,1
290,Blood Clotting Cascade WP272,0.8800596679417653,0.4702927845154968,0.060087225365049436,['F8A1'],0.9988592418816441,0,0,1
291,Glioblastoma signaling pathways WP2261,0.8800596679417653,0.4702927845154968,0.060087225365049436,['HRAS'],0.9988592418816441,0,0,1
292,Chemokine signaling pathway WP3929,0.8823944767635942,0.5764942240080362,0.0721286919141821,"['GNG10', 'GNG3', 'HRAS']",0.9988592418816441,0,0,3
293,B Cell Receptor Signaling Pathway WP23,0.8846336012319544,0.5286975717439294,0.0648086627835859,"['HRAS', 'MEF2D']",0.9988592418816441,0,0,2
294,Pathways Regulating Hippo Signaling WP4540,0.8846336012319544,0.5286975717439294,0.0648086627835859,"['PRKAR1A', 'KIT']",0.9988592418816441,0,0,2
295,Ciliopathies WP4803,0.8983598747062046,0.5512851309152054,0.05908924295434628,"['SMO', 'NEK2', 'CCNQ']",0.9988592418816441,0,0,3
296,Endoderm differentiation WP2853,0.902524357200006,0.4974678613167121,0.05102010514411075,"['TCEAL2', 'NME1']",0.9988592418816441,0,0,2
297,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9030062237960391,0.4231532524807056,0.04317256317022689,['ACTG1'],0.9988592418816441,0,0,1
298,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9030062237960391,0.4231532524807056,0.04317256317022689,['HRAS'],0.9988592418816441,0,0,1
299,TGF-beta Receptor Signaling WP560,0.9030062237960391,0.4231532524807056,0.04317256317022689,['HRAS'],0.9988592418816441,0,0,1
300,White fat cell differentiation WP4149,0.9030062237960391,0.4231532524807056,0.04317256317022689,['DDIT3'],0.9988592418816441,0,0,1
301,Head and Neck Squamous Cell Carcinoma WP4674,0.9030062237960391,0.4231532524807056,0.04317256317022689,['HRAS'],0.9988592418816441,0,0,1
302,Pregnane X receptor pathway WP2876,0.9030062237960391,0.4231532524807056,0.04317256317022689,['PSMC5'],0.9988592418816441,0,0,1
303,Metapathway biotransformation Phase I and II WP702,0.9034405614270975,0.6032273374466065,0.06125469472647055,"['GPX4', 'GSTO1', 'GSTP1', 'KCNAB1', 'SULT4A1']",0.9988592418816441,0,0,5
304,Complement system WP2806,0.9147086476429683,0.5863172142241909,0.052269993368593184,"['FKBP2', 'RPS19', 'CD59', 'TXN', 'CALR']",0.9988592418816441,0,0,5
305,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9155395773010857,0.6541751371255418,0.05772551674099798,"['GNG10', 'GNG3', 'RAB14', 'BAD', 'CDC37', 'KIT', 'PELO', 'HRAS', 'HSP90B1']",0.9988592418816441,0,0,9
306,Pathogenic Escherichia coli infection WP2272,0.9177971435179104,0.4697081187147412,0.0402910407376012,"['ARPC5L', 'ACTG1']",0.9988592418816441,0,0,2
307,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9215665624503263,0.38458454445224016,0.03141297010638865,['HRAS'],0.9988592418816441,0,0,1
308,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9215665624503263,0.38458454445224016,0.03141297010638865,['CALM2'],0.9988592418816441,0,0,1
309,Differentiation Pathway WP2848,0.9215665624503263,0.38458454445224016,0.03141297010638865,['KIT'],0.9988592418816441,0,0,1
310,IL-4 signaling pathway WP395,0.9215665624503263,0.38458454445224016,0.03141297010638865,['BAD'],0.9988592418816441,0,0,1
311,NRF2 pathway WP2884,0.9274452090593923,0.5886144485123498,0.044335358521612016,"['FTH1', 'PRDX1', 'GSTP1', 'TXN', 'SLC39A3', 'FTL']",0.9999768298968404,0,0,6
312,Osteoblast differentiation WP4787,0.9307982835380566,0.4448704542813989,0.03190285770202602,"['SMO', 'DLL3']",0.9999768298968404,0,0,2
313,Prostaglandin Synthesis and Regulation WP98,0.9365783559696216,0.35244395442851895,0.023092865083637615,['S100A6'],0.9999768298968404,0,0,1
314,T-cell receptor (TCR) signaling pathway WP69,0.9487194424565302,0.32524807056229327,0.017121760646757363,['HRAS'],0.9999768298968404,0,0,1
315,Male infertility WP4673,0.9487194424565302,0.32524807056229327,0.017121760646757363,['HMGA1'],0.9999768298968404,0,0,1
316,Oncostatin M Signaling Pathway WP2374,0.9487194424565302,0.32524807056229327,0.017121760646757363,['HRAS'],0.9999768298968404,0,0,1
317,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9487194424565302,0.32524807056229327,0.017121760646757363,['STMN1'],0.9999768298968404,0,0,1
318,Apoptosis Modulation and Signaling WP1772,0.9563458297750907,0.4820480404551201,0.02151654435297733,"['ENDOG', 'BAD', 'CYCS', 'BAX']",0.9999768298968404,0,0,4
319,Vitamin A and carotenoid metabolism WP716,0.9585382959452269,0.3019373129626713,0.012785765973106713,['CRABP1'],0.9999768298968404,0,0,1
320,Mesodermal commitment pathway WP2857,0.9657635745399834,0.367117765620501,0.012788995828389663,"['PRKAR1A', 'RPL38']",0.9999768298968404,0,0,2
321,Vitamin B12 metabolism WP1533,0.9664786933971368,0.2817346563763322,0.009606032081834763,['SOD1'],0.9999768298968404,0,0,1
322,Microglia Pathogen Phagocytosis Pathway WP3937,0.9664786933971368,0.2817346563763322,0.009606032081834763,['RAC3'],0.9999768298968404,0,0,1
323,Neural Crest Differentiation WP2064,0.9728996823324974,0.26405733186328556,0.007254791281473914,['DLL3'],0.9999768298968404,0,0,1
324,MAPK Signaling Pathway WP382,0.9741518446013706,0.4679463516672819,0.012254620958504565,"['GADD45A', 'DDIT3', 'STMN1', 'RAC3', 'HRAS']",0.9999768298968404,0,0,5
325,Ebola Virus Pathway on Host WP4217,0.9800679012723807,0.32450331125827814,0.006533362334774111,"['CLEC4G', 'ACTG1']",0.9999768298968404,0,0,2
326,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9822898721677467,0.2345951243415411,0.004191940085898162,['NDUFA13'],0.9999768298968404,0,0,1
327,PI3K-Akt signaling pathway WP4172,0.984029620352092,0.48232382962464293,0.007765066576297735,"['GNG10', 'GNG3', 'BAD', 'CDC37', 'KIT', 'HRAS', 'HSP90B1']",0.9999768298968404,0,0,7
328,ESC Pluripotency Pathways WP3931,0.9856841694465517,0.22218998433238554,0.0032038219645466512,['HRAS'],0.9999768298968404,0,0,1
329,Wnt signaling pathway and pluripotency WP399,0.9906469745937251,0.200924030030976,0.0018880910682676463,['PPM1J'],0.9999768298968404,0,0,1
330,Peptide GPCRs WP24,0.992440470377606,0.1917410043099128,0.0014549782326569538,['HCRTR1'],0.9999768298968404,0,0,1
331,Nuclear Receptors Meta-Pathway WP2882,0.9939853455856927,0.4951391136524376,0.002987082823331133,"['PSMC5', 'FTH1', 'CDC37', 'PRDX1', 'GSTP1', 'AIP', 'BAX', 'DBI', 'TXN', 'SLC39A3', 'FTL']",0.9999768298968404,0,0,11
332,Vitamin D Receptor Pathway WP2877,0.9973351159703874,0.316830856570379,0.0008454444965335918,"['CDKN2D', 'GADD45A', 'PNOC', 'S100A6']",0.9999768298968404,0,0,4
333,"GPCRs, Other WP117",0.9973937039671468,0.15602923761688922,0.00040718924165900126,['SMO'],0.9999768298968404,0,0,1
334,Spinal Cord Injury WP2431,0.9980414420584311,0.2680851063829787,0.0005255750669046364,"['GADD45A', 'APEX1', 'MIF']",0.9999768298968404,0,0,3
335,Regulation of toll-like receptor signaling pathway WP1449,0.9994127507851541,0.12367857837732668,7.265148239684233e-05,['CUEDC2'],0.9999768298968404,0,0,1
336,"GPCRs, Class A Rhodopsin-like WP455",0.9999768298968404,0.17384898710865562,4.028145631946524e-06,"['MAS1', 'GPR22', 'HCRTR1']",0.9999768298968404,0,0,3
